Statistics for Safety and efficacy data supporting U.S. FDA approval of intracameral phenylephrine and ketorolac 1.0%/0.3% for pediatric cataract surgery: clinical safety and pupil and pain management
Total visits
| views | |
|---|---|
| Safety and efficacy data supporting U.S. FDA approval of intracameral phenylephrine and ketorolac 1.0%/0.3% for pediatric cataract surgery: clinical safety and pupil and pain management | 80 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| Wilson2020safety.pdf | 426 |
| java.util.UUID:0413e14a-9564-4aca-8b30-b5f4832ab4c9 | 111 |
| java.util.UUID:fbdcbb16-2e09-4a11-8332-e696751720b4 | 10 |
| java.util.UUID:f56b1913-e079-427c-b704-4b4d23283a70 | 4 |
Top country views
| views | |
|---|---|
| United States | 67 |
| China | 2 |
| Canada | 1 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 44 |
| White Plains | 8 |
| Houston | 5 |
| Cambridge | 2 |
| Beijing | 1 |
| Fairfield | 1 |
| San Francisco | 1 |
| Seremban | 1 |
| Toronto | 1 |